MedPath

Armour Thyroid

Armour Thyroid (thyroid tablets, USP)

Approved
Approval ID

82cc78b5-20f2-4a4d-a633-012ed0542c09

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Sep 26, 2023

Manufacturers
FDA

PD-Rx Pharmaceuticals, Inc.

DUNS: 156893695

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

THYROID

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code43063-345
Product Classification
G
Generic Name
THYROID
Product Specifications
Route of AdministrationORAL
Effective DateSeptember 26, 2023
FDA Product Classification

INGREDIENTS (5)

CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61U
Classification: IACT
SODIUM STARCH GLYCOLATE TYPE A POTATOInactive
Code: 5856J3G2A2
Classification: IACT
DEXTROSEInactive
Code: IY9XDZ35W2
Classification: IACT
CALCIUM STEARATEInactive
Code: 776XM7047L
Classification: IACT
SUS SCROFA THYROIDActive
Quantity: 30 mg in 1 1
Code: 6RV024OAUQ
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Armour Thyroid - FDA Drug Approval Details